Tannock, Ian F.

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 5,735

Drug penetration in solid tumours

Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer

Drug Transport and Resistance MechanismsCancer Cells and Metastasis

Cited by 2,805

Drug Resistance and the Solid Tumor Microenvironment

Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute

Cancer Cells and MetastasisDrug Transport and Resistance Mechanisms

Cited by 2,116

Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial

Zimmermann, C., Swami, N., Krzyzanowska, M., Hannon, B., Leighl, N., Oza, A., Moore, M., Rydall, A., Rodin, G., Tannock, I., et al. (2014) · The Lancet

Palliative Care and End-of-Life IssuesPalliative and Oncologic Care

Cited by 1,781

Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

Berthold, D. R., Pond, G. R., Soban, F., de Wit, R., Eisenberger, M., & Tannock, I. F. (2008) · Journal of Clinical Oncology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 1,145

The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour

Tannock, I. F. (1968) · British Journal of Cancer

Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism

Cited by 763

Delivering affordable cancer care in high-income countries

Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology

Economic and Financial Impacts of CancerHealth Systems, Economic Evaluations, Quality of Life

Cited by 718

Cytokines and their relationship to the symptoms and outcome of cancer

Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer

Nutrition and Health in AgingTryptophan and brain disorders

Cited by 652

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors

Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., & Tannock, I. F. (2005) · Clinical Cancer Research

Cancer Cells and MetastasisAngiogenesis and VEGF in Cancer

Cited by 499

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

Halabi, S., Kelly, W. K., Ma, H., Zhou, H., Solomon, N. C., Fizazi, K., Tangen, C. M., Rosenthal, M., Petrylak, D. P., Hussain, M., et al. (2016) · Journal of Clinical Oncology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 461

Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer

Amir, E., Miller, N., Geddie, W., Freedman, O., Kassam, F., Simmons, C., Oldfield, M., Dranitsaris, G., Tomlinson, G., Laupacis, A., et al. (2012) · Journal of Clinical Oncology

Breast Cancer Treatment StudiesHER2/EGFR in Cancer Research

Cited by 434

Impact of Spin in the Abstracts of Articles Reporting Results of Randomized Controlled Trials in the Field of Cancer: The SPIIN Randomized Controlled Trial

Boutron, I., Altman, D. G., Hopewell, S., Vera-Badillo, F., Tannock, I., & Ravaud, P. (2014) · Journal of Clinical Oncology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 368

The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells

Grantab, R., Sivananthan, S., & Tannock, I. F. (2006) · Cancer Research

Cancer Cells and MetastasisMathematical Biology Tumor Growth

Cited by 254

The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer

Pond, G. R., Sonpavde, G., de Wit, R., Eisenberger, M. A., Tannock, I. F., & Armstrong, A. J. (2014) · European Urology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 193

The role of kinin receptors in cancer and therapeutic opportunities

da Costa, P. L. N., Sirois, P., Tannock, I. F., & Chammas, R. (2014) · Cancer Letters

Coagulation, Bradykinin, Polyphosphates, and AngioedemaRenin-Angiotensin System Studies

Cited by 133

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Vera-Badillo, F. E., Shapiro, R., Ocana, A., Amir, E., & Tannock, I. F. (2013) · Annals of Oncology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 117

Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy

Dhillon, H. M., Tannock, I. F., Pond, G. R., Renton, C., Rourke, S. B., & Vardy, J. L. (2018) · Journal of Cancer Survivorship

Cancer-related cognitive impairment studiesCancer survivorship and care

Cited by 88

Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study

Bahl, M., Ennis, M., Tannock, I. F., Hux, J. E., Pritchard, K. I., Koo, J., & Goodwin, P. J. (2005) · Breast Cancer Research and Treatment

Cancer Risks and FactorsCancer, Lipids, and Metabolism

Cited by 80

Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study

Mar Fan, H. G., Houédé-Tchen, N., Chemerynsky, I., Yi, Q.-L., Xu, W., Harvey, B., & Tannock, I. F. (2010) · Annals of Oncology

Menopause: Health Impacts and TreatmentsCancer survivorship and care

Cited by 71

Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothes

Seruga, B., & Tannock, I. F. (2009) · Journal of Clinical Oncology

Breast Cancer Treatment StudiesEstrogen and related hormone effects

Cited by 53